trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


Video on Dry Eyeeye_pic.jpg

In recent years the nosology of Dry Eye has greatly changed. Professor Baudouin, MD, PhD from National Ophthalmologiy Hospital XV-XX, Vision Institute of Paris explains through this didactic video the complexity of the Dry Eye disease. Moving beyond the simple name of Dry Eye syndrome, we now consider the condition to be Dry Eye disease, insisting on the lack of tears, the lacrimal inflammation and hyperevaporation leading to self-sustaining loops of neurogenic and palpebral inflammations.

View the video


vislube_logo.gif

Setting the standard in contact lens comfort

VISLUBE® is a preservative-free contact lens lubricant indicated for sensations of ocular dryness, reduced comfort and blurred vision during hard and soft contact lens wear.

As VISLUBE® has many characteristics similar to those natural tears, it alleviates sensations of eye irritation experienced by contact lens wear.

VISLUBE® is a patented hypotonic formulation that contains 0.18% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, associated with essential ions.

VISLUBE® is available in boxes of 20 (or 60) single dose units of 0.3 ml.

 

 

vislube_box01.jpg

pdf VISLUBE® leaflet
trb_lock.gif Doctor information
Distributors
trb_contact.gifContacts

News-Events
 
 
  • English